This emerging treatment is helping people avoid knee replacement surgery ScienceDaily Nawigacja wpisu AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion – Fortune Europe must rethink medicine pricing or risk losing investments, pharma lobby chief says – Reuters
